{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:06:18Z","timestamp":1788368778998,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.lanepe.2024.101161","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T15:34:47Z","timestamp":1734017687000},"page":"101161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis\/chronic fatigue syndrome and elevated \u03b22-adrenergic receptor autoantibodies: a prospective cohort study"],"prefix":"10.1016","volume":"49","author":[{"given":"Elisa","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Heindrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Wittke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Rust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helma","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Sotzny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"T\u00f6lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4909-2805","authenticated-orcid":false,"given":"Laura","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","article-title":"Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME)","volume":"18","author":"Lim","year":"2020","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.lanepe.2024.101161_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2377-11-62","article-title":"Evidence for a heritable predisposition to chronic fatigue syndrome","volume":"11","author":"Albright","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/j.lanepe.2024.101161_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fped.2019.00012","article-title":"Onset patterns and course of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"7","author":"Chu","year":"2019","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib4","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","article-title":"A\u00a0prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity","volume":"13","author":"Kedor","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanepe.2024.101161_bib5","series-title":"Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness","year":"2015"},{"key":"10.1016\/j.lanepe.2024.101161_bib6","article-title":"Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - a validation study in plasma and cerebrospinal fluid from two Swedish cohorts","volume":"7","author":"Bynke","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.lanepe.2024.101161_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101161_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102527","article-title":"A\u00a0unifying hypothesis of the pathophysiology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): recognitions from the finding of autoantibodies against \u00df2-adrenergic receptors","volume":"19","author":"Wirth","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"13","key":"10.1016\/j.lanepe.2024.101161_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137209","article-title":"Long COVID: association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation","volume":"23","author":"Szewczykowski","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.lanepe.2024.101161_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.981532","article-title":"Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in post COVID syndrome correlate with symptom severity","volume":"13","author":"Sotzny","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101161_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/jon.12751","article-title":"Altered structural brain networks related to adrenergic\/muscarinic receptor autoantibodies in chronic fatigue syndrome","volume":"30","author":"Fujii","year":"2020","journal-title":"J\u00a0Neuroimaging"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101161_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/jon.13128","article-title":"Free-water-corrected diffusion and adrenergic\/muscarinic antibodies in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"33","author":"Kimura","year":"2023","journal-title":"J\u00a0Neuroimaging"},{"key":"10.1016\/j.lanepe.2024.101161_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928945","article-title":"Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Gravelsina","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib14","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41467-022-28905-5","article-title":"Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity","volume":"13","author":"Cabral-Marques","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41467-024-45107-3","article-title":"Deep phenotyping of post-infectious myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"15","author":"Walitt","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101161_bib16","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review","volume":"9","author":"Cortes Rivera","year":"2019","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101161_bib17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.transci.2017.08.012","article-title":"Immunoadsorption for collagen and rheumatic diseases","volume":"56","author":"Yamaji","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.lanepe.2024.101161_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.transci.2017.08.013","article-title":"Immunoadsorption in neurological disorders","volume":"56","author":"Oji","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101161_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193672","article-title":"Immunoadsorption to remove \u00df2 adrenergic receptor antibodies in chronic fatigue syndrome CFS\/ME","volume":"13","author":"Scheibenbogen","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lanepe.2024.101161_bib20","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: efficacy of repeat immunoadsorption","volume":"9","author":"Tolle","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"19","key":"10.1016\/j.lanepe.2024.101161_bib21","article-title":"Observational study of repeat immunoadsorption (RIA) in post-COVID ME\/CFS patients with elevated \u00df2-adrenergic receptor autoantibodies-an interim report","volume":"12","author":"Stein","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.lanepe.2024.101161_bib22","article-title":"Fighting post-COVID and ME\/CFS - development of curative therapies","volume":"10","author":"Scheibenbogen","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"11","author":"Carruthers","year":"2003","journal-title":"J\u00a0Chronic Fatigue Syndrome"},{"issue":"3","key":"10.1016\/j.lanepe.2024.101161_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/diagnostics8030066","article-title":"A\u00a0brief questionnaire to assess post-exertional malaise","volume":"8","author":"Cotler","year":"2018","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.lanepe.2024.101161_bib25","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.mayocp.2021.07.004","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: essentials of diagnosis and management","volume":"96","author":"Bateman","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"24","key":"10.1016\/j.lanepe.2024.101161_bib26","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 health survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12955-018-1028-2","article-title":"Defining the minimally clinically important difference of the SF-36 physical function subscale for paediatric CFS\/ME: triangulation using three different methods","volume":"16","author":"Brigden","year":"2018","journal-title":"Health Qual Life Outcome"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101161_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lanepe.2024.101161_bib29","series-title":"The Doctor\u2019s Guide to Chronic Fatigue Syndrome: Understanding, Treating, and Living with CFIDS","author":"Bell","year":"1995"},{"issue":"12","key":"10.1016\/j.lanepe.2024.101161_bib30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated composite autonomic symptom score","volume":"87","author":"Sletten","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12967-021-02774-w","article-title":"Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME\/CFS","volume":"19","author":"Jakel","year":"2021","journal-title":"J\u00a0Transl Med"},{"issue":"4","key":"10.1016\/j.lanepe.2024.101161_bib32","article-title":"Endothelial dysfunction in COVID-19 patients assessed with endo-PAT2000","volume":"92","author":"Cimino","year":"2022","journal-title":"Monaldi Arch Chest Dis"},{"issue":"2","key":"10.1016\/j.lanepe.2024.101161_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven\u00a0methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inf"},{"key":"10.1016\/j.lanepe.2024.101161_bib34","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J\u00a0Biomed Inf"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-021-02833-2","article-title":"Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"19","author":"Wirth","year":"2021","journal-title":"J\u00a0Transl Med"},{"issue":"6","key":"10.1016\/j.lanepe.2024.101161_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28864","article-title":"Overview of autoantibodies in COVID-19 convalescents","volume":"95","author":"Dobrowolska","year":"2023","journal-title":"J\u00a0Med Virol"},{"issue":"6 Suppl","key":"10.1016\/j.lanepe.2024.101161_bib37","first-page":"48","article-title":"Autoantibodies in patients with post-COVID syndrome: a possible link with severity?","volume":"27","author":"Ceccarini","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"10.1016\/j.lanepe.2024.101161_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103445","article-title":"Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors","volume":"22","author":"Seibert","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lanepe.2024.101161_bib39","article-title":"Transfer of IgG from long COVID patients induces symptomology in mice","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.lanepe.2024.101161_bib40","article-title":"A\u00a0causal link between autoantibodies and neurological symptoms in long COVID","author":"Santos Guedes de Sa","year":"2024","journal-title":"medRxiv"},{"issue":"10","key":"10.1016\/j.lanepe.2024.101161_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lanepe.2024.101161_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/M18-1451","article-title":"B-lymphocyte depletion in patients with myalgic encephalomyelitis\/chronic fatigue syndrome: a randomized, double-blind, placebo-controlled trial","volume":"170","author":"Fluge","year":"2019","journal-title":"Ann Intern Med"},{"issue":"10206","key":"10.1016\/j.lanepe.2024.101161_bib43","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(19)31817-3","article-title":"Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2\/3 trial","volume":"394","author":"Cree","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanepe.2024.101161_bib44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13063-024-07982-5","article-title":"IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)","volume":"25","author":"Pressler","year":"2024","journal-title":"Trials"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224003302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224003302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:31:32Z","timestamp":1738575092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224003302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":44,"alternative-id":["S2666776224003302"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101161","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of repeated immunoadsorption in patients with post-COVID myalgic encephalomyelitis\/chronic fatigue syndrome and elevated \u03b22-adrenergic receptor autoantibodies: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.101161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101161"}}